Attached files
file | filename |
---|---|
10-K - 10-K - CALLISTO PHARMACEUTICALS INC | a2197674z10-k.htm |
EX-23 - EXHIBIT 23 - CALLISTO PHARMACEUTICALS INC | a2197674zex-23.htm |
EX-21 - EXHIBIT 21 - CALLISTO PHARMACEUTICALS INC | a2197674zex-21.htm |
EX-31.2 - EXHIBIT 31.2 - CALLISTO PHARMACEUTICALS INC | a2197674zex-31_2.htm |
EX-32.1 - EXHIBIT 32.1 - CALLISTO PHARMACEUTICALS INC | a2197674zex-32_1.htm |
EX-31.1 - EXHIBIT 31.1 - CALLISTO PHARMACEUTICALS INC | a2197674zex-31_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Callisto Pharmaceuticals, Inc. (the "Company") on Form 10-K for the year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Bernard Denoyer, Senior Vice President, Finance of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
March 31, 2010 | /s/ BERNARD DENOYER Bernard Denoyer Senior Vice President, Finance |